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Objectives We investigated the utility of digital reactive hyperemia peripheral arterial tonometry (RH-PAT) in predicting isch-
emic heart disease (IHD), including obstructive coronary artery disease (CAD) and nonobstructive coronary artery
disease (NOCAD), in women.
Background IHD is the leading cause of mortality, and its pathogenesis is diverse in women. Fingertip RH-PAT is a new de-
vice that provides noninvasive, automatic, and quantitative evaluation of endothelial dysfunction.
Methods RH-PAT was measured using Endo-PAT2000 (Itamar Medical, Caesarea, Israel) before cardiac catheterization in
140 stable women scheduled for hospitalization to examine chest pain. NOCAD was diagnosed by angiography
with measurement of coronary blood flow and cardiac lactate production during intracoronary acetylcholine
provocation test and cardiac scintigraphy with stress tests.
Results Sixty-eight women (49%) had obstructive CAD and 42 women (30%) had NOCAD. RH-PAT indexes were significantly
attenuated in both obstructive CAD and NOCAD as compared with non-IHD (n  30) (obstructive CAD: median 1.57,
interquartile range [IQR] 1.42 to 1.76; NOCAD: median 1.58, IQR 1.41 to 1.78; non-IHD: median 2.15, IQR 1.85 to
2.48, p  0.001). By multivariate logistic regression analysis, only RH-PAT index was significantly associated with
IHD, including obstructive CAD and NOCAD (odds ratio 0.51; 95% confidence interval: 0.38 to 0.68; p  0.001). In
receiver-operating characteristic analysis, RH-PAT index was a significant predictor of IHD (area under the curve 0.86;
p  0.001). Furthermore, only RH-PAT was useful for the prediction of NOCAD after excluding obstructive CAD (area
under the curve 0.85; p  0.001; RH-PAT index of 1.82 had 81% sensitivity and 80% specificity).
Conclusions RH-PAT indexes were significantly attenuated in women with IHD. Digital RH-PAT can predict patients with IHD,
especially NOCAD before angiography. RH-PAT is potentially useful for identifying high-risk women for IHD.
(Endothelial Dysfunction and Coronary Artery Spasm; NCT00619294) (J Am Coll Cardiol 2010;55:1688–96)
© 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.10.073c
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boronary artery disease (CAD) is the leading cause of
ortality in post-menopausal women (1). Women with
linical features of myocardial ischemia remain a clinical
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apan; and the Department of Medical Science and Cardiorenal Medicine, Yoko-
ama City University Graduate School of Medicine, Yokohama, Japan. This study
as supported in part by a grant-in-aid for Scientific Research (No. C19590869 for
r. Sugiyama) from the Ministry of Education, Science, and Culture in Japan.i
Manuscript received June 28, 2009; revised manuscript received September 24,
009, accepted October 12, 2009.hallenge due to the diverse pathogenic mechanisms of isch-
mic heart diseases (IHD) in women. The WISE (Women’s
schemia Syndrome Evaluation) study found no significant
oronary artery stenoses (i.e., 50% stenosis) in any major
oronary artery in 69% of women suspected of having IHD (2).
onobstructive coronary artery disease (NOCAD) also pre-
ents a high risk for women with myocardial ischemia (3–5).
See page 1697
hus, cardiovascular prognosis of women with NOCAD is not
enign, and there is a need for effective strategies for the
dentification and treatment of these patients.
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April 20, 2010:1688–96 Endothelial Function and Coronary Disease in WomenThe pathogenesis of NOCAD is unclear at present, but it
ould be due to physiological abnormality in coronary circula-
ion, coronary spastic angina, coronary microvascular spasm,
icrocirculatory insufficiency, or diffuse arteriosclerosis. The
ssessment of NOCAD is not yet established enough. Coro-
ary spastic angina can be diagnosed only by the acetylcholine-
rovocation test during coronary angiography (CAG) (6), and
icrovascular coronary spasm can be diagnosed by measure-
ents of coronary blood flow and myocardial lactate produc-
ion during acetylcholine-provocation test (7). Abnormal re-
idual function of the oxygen supply due to microcirculatory
nsufficiency and diffuse arteriosclerosis can be evaluated by the
easurement of coronary blood flow during adenosine-
rovocation and stress myocardial scintigraphy (8,9). Because
lural complicated vascular function tests are necessary,
OCAD is not fully diagnosed definitely in the routine
linical practice.
Vascular endothelial dysfunction is found from the early
hase of arteriosclerosis to the advanced atheroma resulting
n obstructive CAD (10). Furthermore, regarding NOCAD,
ot only coronary spastic angina, but also microvascular
pasm and microcirculatory insufficiency have been shown
o be associated with coronary endothelial dysfunction
7,11,12), thus it could be possible to identify all these
atients with IHD by physiological examination and eval-
ating endothelial dysfunction.
Endothelial dysfunction in peripheral arteries is assessed by
orearm flow-mediated vasodilation (13). However, the results
f forearm flow-mediated vasodilation can vary due to techni-
al problems encountered during measurement, and thus
orearm flow-mediated vasodilation is not standardized among
nstitutions (14). Kuvin et al. (15) described a new method to
valuate endothelial dysfunction called reactive hyperemia pe-
ipheral arterial tonometry (RH-PAT). It is a noninvasive,
utomatic, and quantitative clinical test for digital measure-
ent of hyperemic response. Using this test, the Framingham
eart Study reported that RH-PAT indexes correlated in-
ersely with various cardiovascular risk factors (16), indicating
he practical usefulness of RH-PAT test.
We hypothesized that endothelial function measured by
ngertip RH-PAT is impaired in patients with IHD,
ncluding NOCAD, and that the RH-PAT indexes can
redict the presence of IHD, especially NOCAD, in
omen complaining of chest pain.
ethods
tudy population and protocol. One hundred fifty-eight
onsecutive stable post-menopausal women with angina-
ike chest pain who were referred and scheduled for hospi-
alization at Kumamoto University Hospital between Au-
ust 2006 and April 2009 for CAG were registered. We
xcluded 17 patients for the following reasons: severe aortic
alve regurgitation or stenosis (n  2), hypertrophic cardio-
yopathy (n  6), uncontrolled hypertension (n  1), severeollagen disease (n  6), and neuromuscular disease (n  2). 1RH-PAT was monitored using
ndo-PAT2000 (Itamar Medical,
aesarea, Israel) on the day before
AG. CAG and RH-PAT stud-
es were performed in the fasting
tate in the early morning after
3-day discontinuation of vasodi-
ators. Cardiologists blinded to the
esults of the RH-PAT performed
ardiac catheterization. On the ba-
is of the results of CAG and after
xcluding 1 patient for incomplete
ardiac catheterization data, pa-
ients with atherosclerotic organic
oronary artery stenosis (50%)
ere diagnosed as having obstruc-
ive CAD, whereas those with no
ignificant epicardial coronary ar-
ery stenosis (50%) on CAG
NOCAD suspected) underwent
cetylcholine-provocation test. Pa-
ients who showed myocardial
schemia during acetylcholine-
rovocation test were divided into
groups: patients with epicar-
ial coronary spasm and pa-
ients with microvascular spasm, those with coronary
lood flow decrease by acetylcholine provocation without
picardial coronary spasm. Patients with negative results
n the acetylcholine-provocation test were further exam-
ned by adenosine-induced coronary flow reserve and
tress thallium-201 single-photon emission computed
omography (SPECT). Patients with abnormal results of
hese tests were diagnosed as having microcirculatory insuf-
ciency, and patients who had no abnormal results were
efined as the nonischemic heart disease group (non-IHD
roup) (Fig. 1). The Reynolds Risk Score was calculated for
ach patient as described previously (17).
Risk factors for cardiovascular disease were defined as
urrent smoking (smoking within 1 year), hypertension
140/90 mm Hg or taking antihypertensive medication),
yslipidemia (high-density lipoprotein cholesterol40 mg/dl,
ow-density lipoprotein cholesterol 140 mg/dl, or triglycer-
des 150 mg/dl or taking medication for dyslipidemia), and
iabetes mellitus (symptoms of diabetes plus casual plasma
lucose concentration 200 mg/dl, fasting plasma glucose
oncentration 126 mg/dl, 2-h plasma glucose concentration
200 mg/dl during 75-g oral glucose tolerance test, or taking
edication for diabetes mellitus).
Written informed consent was obtained from each pa-
ient before participation. The study was conducted in
ccordance with the guidelines approved by the ethics
ommittee of our institution.
H-PAT. The principle of RH-PAT has been described
reviously (18). Briefly, a blood pressure cuff was placed on
Abbreviations
and Acronyms
ACh-CBF  acetylcholine-
induced increase in
coronary blood flow ratio
Ad-CFR  adenosine-
induced coronary flow
reserve
AUC  area under the
curve
CAD  coronary artery
disease
CAG  coronary
angiography
IHD  ischemic heart
disease
NOCAD  nonobstructive
coronary artery disease
RH-PAT  reactive
hyperemia peripheral
arterial tonometry
ROC  receiver-operating
characteristic
SPECT  single-photon
emission computed
tomographyupper arm, while the contralateral arm served as a control.
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Endothelial Function and Coronary Disease in Women April 20, 2010:1688–96AT probes were placed on 1 finger of each hand. After a
-min equilibration period, the cuff was inflated to 60 mm
g above the systolic pressure or 200 mm Hg for 5 min and
hen deflated to induce reactive hyperemia.
The RH-PAT data were digitally analyzed online (Endo-
AT2000 software version 3.0.4). The RH-PAT index
eflects the extent of reactive hyperemia and was calculated
s the ratio of the average amplitude of PAT signal over 1
in starting 1.5 min after cuff deflation (control arm, A;
ccluded arm, C) divided by the average amplitude of PAT
ignal of a 2.5-min time period before cuff inflation (base-
ine) (control arm, B; occluded arm, D). Thus RH-PAT
ndex  (C/D)/(A/B)  baseline correction.
ardiac catheterization. After baseline CAG, patients
ithout obstructive CAD underwent the acetylcholine-
rovocation test. A 6-F catheter was placed in the coronary
Figure 1 Flow Chart of Patient Enrollment Used in the Present
ACh  acetylcholine; CAD  coronary artery disease; CBF  coronary blood flow; CFR
NOCAD  nonobstructive coronary artery disease; RH-PAT  reactive hyperemia peripinus to sample blood for measurement of lactate concentra- bions. A 0.014-inch Flow-Wire Doppler flow probe (REF
400J-FloWire, Volcano, San Diego, California) was inserted
nto the proximal side of the left anterior descending coronary
rtery, and acetylcholine was injected into the left coronary
rtery as described previously (6,19). Briefly, incremental doses
20, 50, and 100 g) of acetylcholine were injected into the left
oronary artery, and angiography was performed 1 min after
ach injection. Then, 50 g of acetylcholine was injected into
he right coronary artery, followed by angiography. At baseline
nd acetylcholine-induced coronary spasm or 1 min after the
aximum dose of acetylcholine was injected into the left
oronary artery, paired samples of 2 ml of blood were collected
imultaneously from the main trunk of the left coronary artery
nd coronary sinus to measure the myocardial lactate extraction
ate, as reported previously (20).
Using Flow-Wire, we measured changes in coronary
y
onary flow reserve; IHD  ischemic heart disease;
rterial tonometry; SPECT  single-photon emission computed tomography.Stud
 cor
heral alood flow in response to low-dose acetylcholine (20 g
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April 20, 2010:1688–96 Endothelial Function and Coronary Disease in Womennjected into the left coronary artery) to determine coronary
ndothelial function (21):
Acetylcholine-induced increase in coronary blood flow ratio
ACh-CBF acetylcholine-induced hyperemia
coronary blood flow/baseline coronary blood flow, where
coronary flow(average peak velocity/2)(vessel diameter/2)2
At the end of the acetylcholine test, nitroglycerin was
njected into each coronary artery when acetylcholine-
nduced coronary spasm did not resolve spontaneously
ithin 5 min, angina chest pain persisted for more than 2
in, or upon the development of ischemia-related hemo-
ynamic instability. After intracoronary nitroglycerin, aden-
sine (150 g/kg/min) was injected intravenously until
aximal hyperemia was achieved. Then coronary flow
eserve was calculated using the following equation:
Adenosine-induced coronary flow reserve Ad-CFR
 adenosine-induced hypermia coronary blood flow/
baseline coronary blood flow
Coronary spasm was defined as 90% lumen narrowing of
he epicardial coronary artery associated with chest pain,
ransient ST-segment depression (0.1 mV) or elevation
Baseline Clinical Characteristics of 140 WomenTable 1 Baseline Clinical Characteristics of
n
Age (yrs)
Body mass index (kg/m2)
Hypertension (%)
Diabetes (%)
Dyslipidemia (%)
Current smoking (%)
Family history of CAD (%)
Systolic blood pressure (mm Hg) 1
Diastolic blood pressure (mm Hg)
Fasting blood glucose (mg/dl) 89
Hemoglobin A1c (%)
HOMA-IR 1.0
Total/high-density lipoprotein cholesterol ratio
Triglycerides (mg/dl) 92
Left ventricular ejection fraction (%)
B-type natriuretic peptide (pg/ml) 18
High-sensitivity C-reactive protein (mg/l) 0.5
Reynolds Risk Score (%) 1.3
Mild-to-moderate coronary atherosclerosis (%)
Aspirin (%)
HMG-CoA reductase inhibitors
Calcium-channel blockers (%)
ACE-I or ARB (%)
Beta blockers (%)
Data are mean (SD), median [25th to 75th percentile range], or %. Mil
*Significantly different from non-IHD. †Significantly different from obs
ACE-I  angiotensin-converting enzyme inhibitors; ARB  angio
3-hydroxy-3-methylglutanyl coenzyme A; HOMA-IR  homeostasis model ass
nonobstructive coronary artery disease.0.1 mV) from baseline levels occurring at 60 to 80 ms after
he J point, and lactate production in the coronary circulation.
icrovascular spasm was defined as decreased coronary blood
ow during acetylcholine provocation associated with chest
ain, transient ST-segment depression or elevation, and myo-
ardial lactate production without epicardial coronary spasm.
n a subject without positive results in acetylcholine-
rovocation test, we defined the patients who showed Ad-
FR 3.0 and myocardial perfusion abnormality in
denosine-provocation thallium SPECT as having microcir-
ulatory insufficiency.
tatistical analysis. The results of normally distributed con-
inuous variables were expressed as mean (SD), whereas those
ith skewed distribution were expressed as the median value
interquartile range [IQR]). Continuous variables were ana-
yzed by the unpaired t test and Mann-Whitney U test, as
ppropriate. Categorical variables were presented by percent,
nd intergroup comparisons were analyzed by chi-square test
and Fisher exact test). Pearson’s correlation coefficient was
sed for evaluation of possible association between ln[RH-
AT index] and ln[ACh-CBF]; ln[RH-PAT index] and
n[Ad-CFR]. Associations between the presence of IHD or
OCAD and other significant parameters in simple logistic
nalysis were analyzed by multiple logistic regression analysis
ith the forced entry method, and the Hosmer-Lemeshow
Chest PainWomen With Chest Pain
D Obstructive CAD NOCAD
68 42
0) 73 (9)* 64 (10)†
) 24 (5) 24 (4)
84* 62†
50* 29†
91* 64†
7 14
19 21*
7) 131 (20) 130 (17)
3) 72 (12) 78 (12)†
94] 97 [88–115] 92 [86–105]
.6) 6.1 (1.2)* 5.6 (1.0)†
1.7] 1.4 [1.0–2.5]* 1.4 [0.8–1.8]
.2) 3.5 (1.1) 3.3 (0.9)
123] 101 [76–136] 99 [80–139]
) 65 (7) 66 (5)
26] 48 [21–120]* 20 [12–30]†
1.0] 1.2 [0.5–2.8]* 0.5 [0.3–0.9]†
3.5] 5.6 [2.6–10.2]* 1.8 [1.0–4.0]†
— 43
90* 46†
79* 38†
71* 49†
62* 29†
46* 0†
derate coronary atherosclerosis: 25% but 50% coronary stenosis.
CAD.
II receptor blockers; CAD  coronary artery disease; HMG-CoA With140
Non-IH
30
63 (1
23 (3
53
20
67
3
3
24 (1
77 (1
[85–
5.5 (0
[0.8–
3.5 (1
[65–
66 (7
[10–
[0.3–
[0.5–
33
27
33
46
27
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d-to-mo
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tensinessment insulin resistance; IHD  ischemic heart disease; NOCAD 
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Endothelial Function and Coronary Disease in Women April 20, 2010:1688–96oodness-of-fit statistic was calculated. Receiver-operating
haracteristics (ROC) curves were constructed for Reynolds
isk Score and RH-PAT index. The area under the curve
AUC), sensitivity, and specificity were calculated to predict
he ability to detect subjects with obstructive CAD,
OCAD, and IHD, with an AUC value of 0.50 indicating
o accuracy and a value of 1.00 indicating maximal accuracy.
UC values are compared using an algorithm suggested by
eLong et al. (22,23). We defined optimal thresholds of
H-PAT index by maximizing the sum of sensitivity and
Figure 2 Acetylcholine-Provocation Test
(A to C) Non-IHD group. (D to F) Epicardial coronary spasm group. (E) Coronary a
*Sampling catheter in the coronary sinus. RH-PAT results of representative (G) nopecificity (24). A p value of 0.05 denoted statistical
ignificance; all tests were 2-tailed. Statistical analyses were
erformed using SPSS version 17.0J (SPSS Inc., Tokyo,
apan) and STATA version 10 (Stata Corp., College
tation, Texas).
esults
linical characteristics of stable women with chest pain.
AG indicated that 68 patients (49%) had obstructive
AD (30 patients had single-vessel disease, 38 patients had
pasm after intracoronary injection of acetylcholine.
and (H) NOCAD cases. Abbreviations as in Figure 1.rtery s
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April 20, 2010:1688–96 Endothelial Function and Coronary Disease in Womenultivessel disease), and 72 patients (51%) were suspected
o have NOCAD (44 patients had no stenosis, 28 patients
ad mild-to-moderate coronary atherosclerosis [25% to
0% coronary artery stenosis]) (Table 1). Among the latter
roup (n  72; NOCAD suspected), coronary spasm was
nduced in 32 patients (15 with ST-segment elevation, 17
ith ST-segment depression) and microvascular spasm was
nduced in 6 patients (1 with ST-segment elevation, 5 with
T-segment depression). Among another 34 patients with-
ut positive results in acetylcholine-provocation test, 4
atients were diagnosed as having microcirculatory insuffi-
iency, and 30 patients had no evidence of myocardial
schemia (non-IHD group) (Fig. 1).
Figure 3 RH-PAT Index and IHD
Box-and-whisker plots of RH-PAT indexes. In these plots, lines within the boxes
represent median values; the upper and lower lines of the boxes represent
25th and 75th percentiles, respectively; and the upper and lower bars outside
the boxes represent the 90th and 10th percentiles, respectively. Abbreviations
as in Figure 1.
ogistic Regression Analysis for the Presence of Ischemic Heart DiTable 2 Logistic Regression Analysis for the Presence of Ische
Variable
Simple
OR 95
Age (per yr) 1.06 1.02
Body mass index (per kg/m2) 1.06 0.95
Current smoking (yes) 3.22 0.40
Systolic blood pressure (per mm Hg) 1.02 1.00
Diastolic blood pressure (per mm Hg) 0.98 0.95
Ln[Fasting blood glucose] (per 0.1) 1.23 0.96
Total/High-density lipoprotein cholesterol (per 1) 0.95 0.65
Ln[Triglycerides] (per 0.1) 1.03 0.94
Ln[B-type natriuretic peptide] (per 0.1) 1.05 1.01
Ln[High-sensitivity C-reactive protein] (per 0.1) 1.01 0.99
Left ventricular ejection fraction (per %) 0.98 0.92
Ln[Reynolds Risk Score] (per 0.1) 1.07 1.04
Ln[RH-PAT index] (per 0.1) 0.50 0.38I  confidence interval; OR  odds ratio; RH-PAT  reactive hyperemia peripheral arterial tonometry; oPatients in the obstructive CAD group were significantly
lder, had a higher prevalence of conventional cardiovascu-
ar risk factors, higher homeostasis model assessment insulin
esistance, B-type natriuretic peptide, high-sensitivity
-reactive protein, and Reynolds Risk Score. In contrast,
atients in the NOCAD group were not significantly
ifferent from those in the non-IHD group, except for
amily history of CAD (Table 1).
H-PAT indexes and IHD including obstructive CAD
nd NOCAD. Figure 2 shows representative records of
H-PAT signals and CAG in patients with non-IHD and
OCAD. RH-PAT indexes were lower in patients with
bstructive CAD and NOCAD than in non-IHD patients
non-IHD: median 2.15 [IQR 1.85 to 2.48]; obstructive-
AD: median 1.57 [IQR 1.42 to 1.76]; NOCAD: median
.58 [IQR 1.41 to 1.78]; p  0.001) (Fig. 3). There was no
ignificant difference in RH-PAT indexes between
OCAD and obstructive CAD groups.
H-PAT indexes and ACh-CBF among patients with
OCAD. We were successful in obtaining complete cor-
nary flow data from 51 patients without obstructive CAD.
Ch-CBF was attenuated in patients with NOCAD rela-
ive to the non-IHD group (NOCAD: median 1.52 [IQR
.23 to 1.90]; non-IHD: median 2.12 [IQR 1.82 to 2.42];
 0.001). However, Ad-CFR was comparable in the 2
roups (NOCAD: median 3.25 [IQR 3.01 to 3.58]; non-
HD: median 3.09 [IQR 2.78 to 3.60]; p  0.36). There
as a significant correlation between ln[RH-PAT index]
nd ln[ACh-CBF] (r  0.52; p  0.001), but not Ad-CFR
r  0.21; p  0.12).
H-PAT indexes and presence of IHD. Simple logistic
egression analysis demonstrated that age, B-type natri-
retic peptide, Reynolds Risk Score, and RH-PAT index
ignificantly predicted the presence of IHD in women
omplaining of chest pain (Table 2). Multiple logistic
egression analysis identified only RH-PAT index as the
e in Female Patients Complaining of Chest Paineart Disease in Female Patients Complaining of Chest Pain
ssion Multiple Regression
p Value OR 95% CI p Value
0.004 0.99 0.92–1.07 0.81
0.28
0.27
0.06
0.24
0.10
0.81
0.54
0.01 1.03 0.98–1.09 0.21
0.31
0.60
0.001 1.06 1.00–1.13 0.05
0.001 0.51 0.38–0.68 0.001seasmic H
Regre
% CI
–1.10
–1.18
–26.0
–1.05
–1.01
–1.57
–1.42
–1.12
–1.09
–1.03
–1.05
–1.11
–0.65ther abbreviations as in Table 1.
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Endothelial Function and Coronary Disease in Women April 20, 2010:1688–96ignificant predictor of IHD, including obstructive CAD
nd NOCAD (odds ratio: 0.51; 95% confidence interval
CI]: 0.38 to 0.68; p  0.001) (Table 2). Hosmer-
emeshow goodness of fit chi-square and p are 12.1 and
.15, respectively. Furthermore, we found that only RH-
AT index was also a significant factor for predicting
OCAD in women complaining of chest pain by multiple
ogistic regression analysis (odds ratio: 0.78; 95% CI: 0.63 to
.96; p  0.02). Hosmer-Lemeshow goodness of fit chi-
Figure 4 ROC Curves to Identify Obstructive CAD and IHD
Receiver-operating characteristic (ROC) curves for the Reynolds Risk Score
(RRS) and RH-PAT index to identify patients with obstructive CAD and patients
with IHD in stable women complaining of chest pain. AUC  area under the
curve; other abbreviations as in Figure 1.quare is 11.4 and the p value is 0.18.OC analysis for Reynolds Risk Score and RH-PAT
ndex to predict patients with obstructive CAD and IHD
n women complaining of chest pain. ROC curves were
onstructed to assess the ability of Reynolds Risk Score
nd RH-PAT index to predict obstructive CAD and
HD. The AUC for detection of obstructive CAD was
.78 (95% CI: 0.70 to 0.85; p  0.001) of Reynolds Risk
core and 0.66 (95% CI: 0.57 to 0.75; p 0.001) of RH-PAT
ndex (Fig. 4A). The AUC for detection of IHD, including
bstructive CAD and NOCAD, was 0.73 (95% CI: 0.63 to
.83; p  0.001) of Reynolds Risk Score and 0.86 (95% CI:
.79 to 0.93; p  0.001) of RH-PAT index (Fig. 4B).
here was no significant (borderline) difference between
UCs of RH-PAT index and Reynolds Risk Score for
rediction of obstructive CAD (p  0.06) or IHD (p 
.05). Reynolds Risk Score was comprehensively useful for
rediction of obstructive CAD, and RH-PAT index was
articularly useful for prediction of overall IHD. Using an
H-PAT index cutoff value of 1.82, the sensitivity and
pecificity for the detection of IHD were 80% and 80%,
espectively.
H-PAT index has high ability to predict NOCAD,
articularly in patients without obstructive CAD. We
an diagnose obstructive CAD simply on anatomical exam-
nation such as CAG or multidetector computed tomo-
raphic CAG. Therefore, we examined whether RH-PAT
as useful for a prediction of NOCAD after excluding the
resence of obstructive CAD. We found that only the
H-PAT index was a significantly associated factor of
OCAD in women without obstructive CAD by simple
ogistic regression analysis (odds ratio 0.49; 95% CI: 0.35 to
Figure 5 ROC Curves to Identify NOCAD
Receiver-operating characteristic (ROC) curves for Reynolds Risk Score (RRS)
and RH-PAT index to identify patients with NOCAD among women without
obstructive CAD. Abbreviations as in Figures 1 and 4.
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AD, Reynolds Risk Score could not predict NOCAD
AUC 0.59; 95% CI: 0.45 to 0.73; p 0.22), but RH-PAT
ndex could significantly predict NOCAD (AUC 0.85; 95%
I: 0.76 to 0.94; p  0.001) (Fig. 5). The AUC of
H-PAT index for prediction of NOCAD was significantly
igher compared with Reynolds Risk Score (p  0.003).
he cutoff value of RH-PAT index of1.82 had sensitivity
f 81% and specificity 80% for prediction of NOCAD in
atients without obstructive CAD.
iscussion
he present study of stable women complaining of angina-
ike symptoms showed significant impairment of digitally
ecorded endothelial function in patients with IHD, espe-
ially NOCAD, and such impairment was equivalent to that
een in patients with organic obstructive CAD. Reynolds
isk Score and RH-PAT index significantly predicted
HD. RH-PAT index was particularly superior in predict-
ng NOCAD. In other words, noninvasive measurement of
H-PAT can predict patients with IHD, including
OCAD, before angiography. Thus, RH-PAT is poten-
ially useful for identification of women at high risk for
HD.
Over the years, cardiovascular mortality has declined
ubstantially, but this improvement in prognosis had been
estricted to men (25,26). IHD is sometimes not diagnosed
orrectly in women; therefore, the prognosis of such women
s worse than that of men (2). It is important that more
omen are diagnosed correctly with IHD and receive
ppropriate treatment. NOCAD is more common in
omen, and women have been recognized recently as a
igh-risk population (3–5). The underlying mechanisms of
OCAD are not fully known, though it is likely caused by
multitude of pathogenic mechanisms (3). Women with
yocardial ischemia are still a clinical challenge. Obstruc-
ive CAD could be diagnosed by CAG (anatomical exam-
nation), but NOCAD cannot be simply diagnosed with
natomical tests. Although the Reynolds Risk Score pre-
icts obstructive CAD well, it may not be useful for
rediction of NOCAD in women. The design of a new and
oninvasive test for the assessment of NOCAD is strongly
esirable. Coronary endothelial dysfunction plays an impor-
ant pathogenic role in NOCAD (7,11,12,27). The present
tudy demonstrated that noninvasive digital assessment of
eripheral endothelial function by RH-PAT significantly
redicted IHD, particularly NOCAD. Thus, RH-PAT can
otentially provide useful and noninvasive clinical assess-
ent of IHD, including NOCAD, in women. We could
oninvasively provide superior identification of high-risk
atients for IHD with a combination of the physiological
xamination with RH-PAT and the anatomical examina-
ion with computed tomography.
The vascular endothelium plays a crucial role in regula-
ion of vasomotor tone, thrombosis, and platelet adhesion10,13), and endothelial dysfunction is a significant risk
actor of future cardiovascular events (28,29). Invasive mea-
urement of coronary vasodilator response by acetylcholine
nfusion is an established method for assessment of coronary
ndothelial function (21). On the other hand, digital RH-
AT can evaluate peripheral endothelial function, and the
esults are correlated with traditional and metabolic cardio-
ascular risk factors (15,16,18). Bonetti et al. (30) demon-
trated that RH-PAT index significantly predicted coronary
ndothelial dysfunction. Similar to their study, we also
ound that RH-PAT index was correlated significantly with
Ch-CBF. In addition, we also found that RH-PAT index
as significantly attenuated in patients with NOCAD who
ere diagnosed by simultaneous measurement of coronary
ow and cardiac lactate production. Measurement of RH-
AT index, which can reflect coronary endothelial function,
ay also have a useful predictive value for future cardiovas-
ular events. Recently, Rubinshtein et al. (31) reported that
ssessment of peripheral vascular function by RH-PAT in
ddition to the Framingham Risk Score may be useful for
dentification of risk for cardiac events.
Our results showed significant impairment of RH-PAT
ndex in women with IHD. Endothelial dysfunction could
e a modifiable risk factor of future cardiovascular events
nd a potential clinical therapeutic target. Because RH-
AT is a noninvasive, quantitative, and repeatable test, the
alues of RH-PAT index could be used for evaluation of
ascular condition and treatment efficacy.
tudy limitation. The predictive value of RH-PAT index
n NOCAD is limited to a modest number of patients and
eeds confirmation in larger patient populations.
onclusions
igital fingertip endothelial function was significantly im-
aired in post-menopausal women with NOCAD equiva-
ent to those with obstructive CAD. RH-PAT noninva-
ively predicted the presence of IHD, especially NOCAD,
efore CAG. RH-PAT is a potentially useful clinical test
nd can effectively help to identify high-risk women with
hest pain.
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